CAR T-cell therapy: a new treatment option for autoimmune diseases
CAR T-cell therapy, a revolutionary technology originally developed for blood cancers, may also help in restoring the immune system in severe autoi...
CAR T-cell therapy, a revolutionary technology originally developed for blood cancers, may also help in restoring the immune system in severe autoi...
The Clínic Barcelona Comprehensive Cancer Center (4CB), driven by Hospital Clínic Barcelona, IDIBAPS, and the University of Barcelona, has announce...
This comprehensive preparation, which combines supervised physical exercise, nutritional advice and psychological support, has been associated with...
Last Tuesday, 15 October 2024, IDIBAPS received a visit from thirty people, most of them patients with liver cancer under treatment at the Hospital...
The Joan Rodés-Josep Baselga Advanced Research Contracts in Oncology and Neurodegenerative Diseases, awarded by the BBVA Foundation and Hospital Cl...
Interview with Dr. M. José Ribal, Head of the Urological Onocology Unit. Dra. Ribal has been appointed the new president of the Office of Clinical...
The IDIBAPS governing board has approved the creation of a new research group. The decision is in response to the results of scientific evaluation,...
Dr. Aleix Prat, head of the Service of Medical Oncology at Hospital Clínic, head of the Translational genomics and targeted therapies in solid tumo...
Hospital Clínic of Barcelona will apply the leading comprehensive liquid biopsy test currently available for patients with advanced cancer, in the...